Product Features
InVivage® incorporates OptiScan's latest confocal technology
Optimised for imaging cellular architecture, in clinical and research settings
Features button-controlled, miniaturised hand-held endomicroscopic probe (4mm diameter tip)
Produces real-time, sub-cellular, high resolution images at 1000x real magnification
DICOM-compatible/PACS-enabled allowing image transmission and storage
The InVivage® is currently an unapproved device and is not available for sale, pending appropriate regulatory approvals.
OptiScan is seeking interest from investigational and research organisations to further develop the clinical use possibilities as outlined below.
For expressions of interest please contact our CEO, Prof Camile Farah (CFarah@optiscan.com)
OptiScan confocal technology has the unique ability to image different tissues
Cervix
Kidney
Oral
Lung
Eye
Blood vessel
OptiScan confocal technology has excellent correlation with current gold standard histopathology
Endometrium
Mesothelioma
Oral carcinoma in situ
OptiScan confocal technology has the potential to distinguish cancer from normal tissue
Oesophagus
Oesophageal cancer
Colon
Adenocarcinoma
Breast
Ductal carcinoma
OptiScan confocal technology has the potential to distinguish normal, precancerous, and cancerous oral tissue
Normal
Pre-cancer
Cancer
Not all images above were produced using InVivage® but were produced using current or earlier OptiScan technology.
Confocal imaging is an adjunctive tool to aid in the diagnostic assessment by a health care practitioner.